In summary, these authors suggest that these results define a double-negative feedback loop involving miR-489 and the HER2-SHP2-MAPK signaling axis that can regulate breast cancer cell proliferation and tumor progression and might have therapeutic relevance for HER2-positive breast cancer [47]. Here, PTPN11 is linked to neoplasm.